# BYQLOVI

NDC: 82667-021
Generic name: clobetasol propionate
Labeler / Manufacturer: Harrow Eye, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: FOR SUSPENSION
Routes: OPHTHALMIC
Marketing started: 20240304

FDA application: NDA218158

## Active ingredients

- CLOBETASOL PROPIONATE: .5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"82667-021"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=82667-021
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31ca5a0f-812e-491d-aa00-d8ed424ba322
